Department of Economics and Business Economics

Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. / Harris, Meredith G.; Bharat, Chrianna; Glantz, Meyer D.; Sampson, Nancy A.; Al-Hamzawi, Ali; Alonso, Jordi; Bruffaerts, Ronny; Caldas de Almeida, José Miguel; Cia, Alfredo H.; de Girolamo, Giovanni; Florescu, Silvia; Gureje, Oye; Haro, Josep Maria; Hinkov, Hristo; Karam, Elie G.; Karam, Georges; Lee, Sing; Lépine, Jean Pierre; Levinson, Daphna; Makanjuola, Victor; McGrath, John; Mneimneh, Zeina; Navarro-Mateu, Fernando; Piazza, Marina; Posada-Villa, José; Rapsey, Charlene; Tachimori, Hisateru; ten Have, Margreet; Torres, Yolanda; Viana, Maria Carmen; Chatterji, Somnath; Zaslavsky, Alan M.; Kessler, Ronald C.; Degenhardt, Louisa; on behalf of the World Health Organization's World Mental Health Surveys collaborators.

In: Addiction, Vol. 114, No. 8, 2019, p. 1446-1459.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Harris, MG, Bharat, C, Glantz, MD, Sampson, NA, Al-Hamzawi, A, Alonso, J, Bruffaerts, R, Caldas de Almeida, JM, Cia, AH, de Girolamo, G, Florescu, S, Gureje, O, Haro, JM, Hinkov, H, Karam, EG, Karam, G, Lee, S, Lépine, JP, Levinson, D, Makanjuola, V, McGrath, J, Mneimneh, Z, Navarro-Mateu, F, Piazza, M, Posada-Villa, J, Rapsey, C, Tachimori, H, ten Have, M, Torres, Y, Viana, MC, Chatterji, S, Zaslavsky, AM, Kessler, RC, Degenhardt, L & on behalf of the World Health Organization's World Mental Health Surveys collaborators 2019, 'Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys', Addiction, vol. 114, no. 8, pp. 1446-1459. https://doi.org/10.1111/add.14599

APA

Harris, M. G., Bharat, C., Glantz, M. D., Sampson, N. A., Al-Hamzawi, A., Alonso, J., Bruffaerts, R., Caldas de Almeida, J. M., Cia, A. H., de Girolamo, G., Florescu, S., Gureje, O., Haro, J. M., Hinkov, H., Karam, E. G., Karam, G., Lee, S., Lépine, J. P., Levinson, D., ... on behalf of the World Health Organization's World Mental Health Surveys collaborators (2019). Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction, 114(8), 1446-1459. https://doi.org/10.1111/add.14599

CBE

Harris MG, Bharat C, Glantz MD, Sampson NA, Al-Hamzawi A, Alonso J, Bruffaerts R, Caldas de Almeida JM, Cia AH, de Girolamo G, Florescu S, Gureje O, Haro JM, Hinkov H, Karam EG, Karam G, Lee S, Lépine JP, Levinson D, Makanjuola V, McGrath J, Mneimneh Z, Navarro-Mateu F, Piazza M, Posada-Villa J, Rapsey C, Tachimori H, ten Have M, Torres Y, Viana MC, Chatterji S, Zaslavsky AM, Kessler RC, Degenhardt L, on behalf of the World Health Organization's World Mental Health Surveys collaborators. 2019. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction. 114(8):1446-1459. https://doi.org/10.1111/add.14599

MLA

Vancouver

Author

Harris, Meredith G. ; Bharat, Chrianna ; Glantz, Meyer D. ; Sampson, Nancy A. ; Al-Hamzawi, Ali ; Alonso, Jordi ; Bruffaerts, Ronny ; Caldas de Almeida, José Miguel ; Cia, Alfredo H. ; de Girolamo, Giovanni ; Florescu, Silvia ; Gureje, Oye ; Haro, Josep Maria ; Hinkov, Hristo ; Karam, Elie G. ; Karam, Georges ; Lee, Sing ; Lépine, Jean Pierre ; Levinson, Daphna ; Makanjuola, Victor ; McGrath, John ; Mneimneh, Zeina ; Navarro-Mateu, Fernando ; Piazza, Marina ; Posada-Villa, José ; Rapsey, Charlene ; Tachimori, Hisateru ; ten Have, Margreet ; Torres, Yolanda ; Viana, Maria Carmen ; Chatterji, Somnath ; Zaslavsky, Alan M. ; Kessler, Ronald C. ; Degenhardt, Louisa ; on behalf of the World Health Organization's World Mental Health Surveys collaborators. / Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. In: Addiction. 2019 ; Vol. 114, No. 8. pp. 1446-1459.

Bibtex

@article{fb373328e07e491784ddc1bdbc7a68e1,
title = "Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys",
abstract = "Aims: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design: Cross-sectional, representative household surveys. Setting: Twenty-seven surveys from 25 countries of the WHO World Mental Health Survey Initiative. Participants: A total of 2446 people with past-year DSM-IV SUD diagnoses (alcohol or illicit drug abuse and dependence). Measurements: Outcomes were SUD treatment, defined as having either received professional treatment or attended a self-help group for substance-related problems in the past 12 months, and MAT, defined as having either four or more SUD treatment visits to a health-care professional, six or more visits to a non-health-care professional or being in ongoing treatment at the time of interview. Covariates were mental disorder comorbidity and several socio-economic characteristics. Pooled estimates reflect country sample sizes rather than population sizes. Findings: Of respondents with past-year SUD, 11.0% [standard error (SE) = 0.8] received past 12-month SUD treatment. SUD treatment was more common among people with comorbid mental disorders than with pure SUDs (18.1%, SE = 1.6 versus 6.8%, SE = 0.7), as was MAT (84.0%, SE = 2.5 versus 68.3%, SE = 3.8) and treatment by health-care professionals (88.9%, SE = 1.9 versus 78.8%, SE = 3.0) among treated SUD cases. Adjusting for socio-economic characteristics, mental disorder comorbidity doubled the odds of SUD treatment [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.71–3.20], MAT among SUD cases (OR = 2.75; 95% CI = 1.90–3.97) and MAT among treated cases (OR = 2.48; 95% CI = 1.23–5.02). Patterns were similar within country income groups, although the proportions receiving SUD treatment and MAT were higher in high- than low-/middle-income countries. Conclusions: Few people with past-year substance use disorders receive adequate 12-month substance use disorder treatment, even when comorbid with a mental disorder. This is largely due to the low proportion of people receiving any substance use disorder treatment, as the proportion of patients whose treatment is at least minimally adequate is high.",
keywords = "Comorbidity, mental disorders, minimally adequate treatment, substance use disorders, treatment, World Mental Health Surveys",
author = "Harris, {Meredith G.} and Chrianna Bharat and Glantz, {Meyer D.} and Sampson, {Nancy A.} and Ali Al-Hamzawi and Jordi Alonso and Ronny Bruffaerts and {Caldas de Almeida}, {Jos{\'e} Miguel} and Cia, {Alfredo H.} and {de Girolamo}, Giovanni and Silvia Florescu and Oye Gureje and Haro, {Josep Maria} and Hristo Hinkov and Karam, {Elie G.} and Georges Karam and Sing Lee and L{\'e}pine, {Jean Pierre} and Daphna Levinson and Victor Makanjuola and John McGrath and Zeina Mneimneh and Fernando Navarro-Mateu and Marina Piazza and Jos{\'e} Posada-Villa and Charlene Rapsey and Hisateru Tachimori and {ten Have}, Margreet and Yolanda Torres and Viana, {Maria Carmen} and Somnath Chatterji and Zaslavsky, {Alan M.} and Kessler, {Ronald C.} and Louisa Degenhardt and {on behalf of the World Health Organization's World Mental Health Surveys collaborators}",
year = "2019",
doi = "10.1111/add.14599",
language = "English",
volume = "114",
pages = "1446--1459",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell Publishing Ltd.",
number = "8",

}

RIS

TY - JOUR

T1 - Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys

AU - Harris, Meredith G.

AU - Bharat, Chrianna

AU - Glantz, Meyer D.

AU - Sampson, Nancy A.

AU - Al-Hamzawi, Ali

AU - Alonso, Jordi

AU - Bruffaerts, Ronny

AU - Caldas de Almeida, José Miguel

AU - Cia, Alfredo H.

AU - de Girolamo, Giovanni

AU - Florescu, Silvia

AU - Gureje, Oye

AU - Haro, Josep Maria

AU - Hinkov, Hristo

AU - Karam, Elie G.

AU - Karam, Georges

AU - Lee, Sing

AU - Lépine, Jean Pierre

AU - Levinson, Daphna

AU - Makanjuola, Victor

AU - McGrath, John

AU - Mneimneh, Zeina

AU - Navarro-Mateu, Fernando

AU - Piazza, Marina

AU - Posada-Villa, José

AU - Rapsey, Charlene

AU - Tachimori, Hisateru

AU - ten Have, Margreet

AU - Torres, Yolanda

AU - Viana, Maria Carmen

AU - Chatterji, Somnath

AU - Zaslavsky, Alan M.

AU - Kessler, Ronald C.

AU - Degenhardt, Louisa

AU - on behalf of the World Health Organization's World Mental Health Surveys collaborators

PY - 2019

Y1 - 2019

N2 - Aims: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design: Cross-sectional, representative household surveys. Setting: Twenty-seven surveys from 25 countries of the WHO World Mental Health Survey Initiative. Participants: A total of 2446 people with past-year DSM-IV SUD diagnoses (alcohol or illicit drug abuse and dependence). Measurements: Outcomes were SUD treatment, defined as having either received professional treatment or attended a self-help group for substance-related problems in the past 12 months, and MAT, defined as having either four or more SUD treatment visits to a health-care professional, six or more visits to a non-health-care professional or being in ongoing treatment at the time of interview. Covariates were mental disorder comorbidity and several socio-economic characteristics. Pooled estimates reflect country sample sizes rather than population sizes. Findings: Of respondents with past-year SUD, 11.0% [standard error (SE) = 0.8] received past 12-month SUD treatment. SUD treatment was more common among people with comorbid mental disorders than with pure SUDs (18.1%, SE = 1.6 versus 6.8%, SE = 0.7), as was MAT (84.0%, SE = 2.5 versus 68.3%, SE = 3.8) and treatment by health-care professionals (88.9%, SE = 1.9 versus 78.8%, SE = 3.0) among treated SUD cases. Adjusting for socio-economic characteristics, mental disorder comorbidity doubled the odds of SUD treatment [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.71–3.20], MAT among SUD cases (OR = 2.75; 95% CI = 1.90–3.97) and MAT among treated cases (OR = 2.48; 95% CI = 1.23–5.02). Patterns were similar within country income groups, although the proportions receiving SUD treatment and MAT were higher in high- than low-/middle-income countries. Conclusions: Few people with past-year substance use disorders receive adequate 12-month substance use disorder treatment, even when comorbid with a mental disorder. This is largely due to the low proportion of people receiving any substance use disorder treatment, as the proportion of patients whose treatment is at least minimally adequate is high.

AB - Aims: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design: Cross-sectional, representative household surveys. Setting: Twenty-seven surveys from 25 countries of the WHO World Mental Health Survey Initiative. Participants: A total of 2446 people with past-year DSM-IV SUD diagnoses (alcohol or illicit drug abuse and dependence). Measurements: Outcomes were SUD treatment, defined as having either received professional treatment or attended a self-help group for substance-related problems in the past 12 months, and MAT, defined as having either four or more SUD treatment visits to a health-care professional, six or more visits to a non-health-care professional or being in ongoing treatment at the time of interview. Covariates were mental disorder comorbidity and several socio-economic characteristics. Pooled estimates reflect country sample sizes rather than population sizes. Findings: Of respondents with past-year SUD, 11.0% [standard error (SE) = 0.8] received past 12-month SUD treatment. SUD treatment was more common among people with comorbid mental disorders than with pure SUDs (18.1%, SE = 1.6 versus 6.8%, SE = 0.7), as was MAT (84.0%, SE = 2.5 versus 68.3%, SE = 3.8) and treatment by health-care professionals (88.9%, SE = 1.9 versus 78.8%, SE = 3.0) among treated SUD cases. Adjusting for socio-economic characteristics, mental disorder comorbidity doubled the odds of SUD treatment [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.71–3.20], MAT among SUD cases (OR = 2.75; 95% CI = 1.90–3.97) and MAT among treated cases (OR = 2.48; 95% CI = 1.23–5.02). Patterns were similar within country income groups, although the proportions receiving SUD treatment and MAT were higher in high- than low-/middle-income countries. Conclusions: Few people with past-year substance use disorders receive adequate 12-month substance use disorder treatment, even when comorbid with a mental disorder. This is largely due to the low proportion of people receiving any substance use disorder treatment, as the proportion of patients whose treatment is at least minimally adequate is high.

KW - Comorbidity

KW - mental disorders

KW - minimally adequate treatment

KW - substance use disorders

KW - treatment

KW - World Mental Health Surveys

UR - http://www.scopus.com/inward/record.url?scp=85066930209&partnerID=8YFLogxK

U2 - 10.1111/add.14599

DO - 10.1111/add.14599

M3 - Journal article

C2 - 30835879

AN - SCOPUS:85066930209

VL - 114

SP - 1446

EP - 1459

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 8

ER -